NOBLEOAK LIFE LIMITED (NOL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NOL - NOBLEOAK LIFE LIMITED

FNArena Sector : Insurance

Year End: June

GICS Industry Group : Insurance

Debt/EBITDA: N/A

Index:

LAST PRICE	CHANGE +/-	CHANGE %	VOLUME
$1.55 18 Sep 2025	0.065 OPEN $1.54	4.38% HIGH $1.58	33,552 LOW $1.54

LAST PRICE

CHANGE +/-

CHANGE %

VOLUME

$1.55

18 Sep
2025

0.065

OPEN

$1.54

4.38%

HIGH

$1.58

33,552

LOW

$1.54

TARGET

$2.85

83.9% upside

OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . IAG . MPL . NHF . QBE . SDF . SUN . TWR .

FNARENA'S MARKET CONSENSUS FORECASTS

Title	FY24 Actual	FY25 Actual	FY26 Forecast	FY27 Forecast
EPS (cps)	xxx	8.0	21.8	xxx
DPS (cps)	xxx	0.0	0.0	xxx
EPS Growth	xxx	- 26.1%	100.0%	xxx
DPS Growth	xxx	N/A	N/A	xxx
PE Ratio	xxx	N/A	6.9	xxx
Dividend Yield	xxx	N/A	0.0%	xxx
Div Pay Ratio(%)	xxx	N/A	N/A	xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

HISTORICAL DATA ARE ALL IN AUD

Copyright © 2025 FactSet UK Limited. All rights reserved

Title	2020	2021	2022	2023	2024	2025
EPS Basic	xxx	xxx	xxx	xxx	xxx	8.0
DPS All	xxx	xxx	xxx	xxx	xxx	0.0
Sales/Revenue	xxx	xxx	xxx	xxx	xxx	476.4 M
Book Value Per Share	xxx	xxx	xxx	xxx	xxx	95.8
Net Operating Cash Flow	xxx	xxx	xxx	xxx	xxx	58.7 M
Net Profit Margin	xxx	xxx	xxx	xxx	xxx	1.49 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title	2020	2021	2022	2023	2024	2025
Return on Capital Employed	xxx	xxx	xxx	xxx	xxx	8.88 %
Return on Invested Capital	xxx	xxx	xxx	xxx	xxx	8.43 %
Return on Assets	xxx	xxx	xxx	xxx	xxx	1.38 %
Return on Equity	xxx	xxx	xxx	xxx	xxx	8.88 %
Return on Total Capital	xxx	xxx	xxx	xxx	xxx	18.12 %
Free Cash Flow ex dividends	xxx	xxx	xxx	xxx	xxx	58.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title	2020	2021	2022	2023	2024	2025
Short-Term Debt	xxx	xxx	xxx	xxx	xxx	1 M
Long Term Debt	xxx	xxx	xxx	xxx	xxx	4 M
Total Debt	xxx	xxx	xxx	xxx	xxx	5 M
Goodwill - Gross	xxx	xxx	xxx	xxx	xxx	0 M
Cash & Equivalents - Generic	xxx	xxx	xxx	xxx	xxx	86 M
Price To Book Value	xxx	xxx	xxx	xxx	xxx	1.59

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title	2020	2021	2022	2023	2024	2025
Capex	xxx	xxx	xxx	xxx	xxx	0.1 M
Capex % of Sales	xxx	xxx	xxx	xxx	xxx	0.02 %
Cost of Goods Sold	xxx	xxx	xxx	xxx	xxx	-
Selling, General & Admin. Exp & Other	xxx	xxx	xxx	xxx	xxx	100 M
Research & Development	xxx	xxx	xxx	xxx	xxx	-
Investments - Total	xxx	xxx	xxx	xxx	xxx	252 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
EXTRA COVERAGE

EXPERT VIEWS

Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY
Shaw and Partners	01/09/2025	1	Buy, High Risk	$2.85	83.87%	According to Shaw and Partners, the highlight of NobleOak Life's FY25 results was a beat at the underlying net profit line and a solid outlook statement, pointing to continued momentum in the business. Underlying net profit was 5% ahead of forecast, helped by growth in the direct channel. Premium growth is guided to be at least 15% in FY26, and the underlying net profit is expected to grow at least 10%. The insurer published its first Embedded Value since the IPO, at $2.16/share at the midpoint. The broker notes this compares favourably with the current share price, with the target price accounting for upside potential. FY26 underlying net profit forecast lifted by 5% and FY27 by 4.8%. Buy, High Risk. Target unchanged at $2.85. FORECAST Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 21.80 cents. Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 23.70 cents.

BROKER

DATE

RATING

RECOMMENDATION

TARGET PRICE

% TO REACH TARGET

COMMENTARY

Shaw and Partners

01/09/2025

Buy, High Risk

$2.85

83.87%

According to Shaw and Partners, the highlight of NobleOak Life's FY25 results was a beat at the underlying net profit line and a solid outlook statement, pointing to continued momentum in the business.

Underlying net profit was 5% ahead of forecast, helped by growth in the direct channel. Premium growth is guided to be at least 15% in FY26, and the underlying net profit is expected to grow at least 10%.

The insurer published its first Embedded Value since the IPO, at $2.16/share at the midpoint. The broker notes this compares favourably with the current share price, with the target price accounting for upside potential.

FY26 underlying net profit forecast lifted by 5% and FY27 by 4.8%.

Buy, High Risk. Target unchanged at $2.85.

FORECAST
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 21.80 cents.
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 23.70 cents.

Access Stockbroker Research History >

EXTRA COVERAGE

Display All Commentary

No. Of Recommendations

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY

Access Extra Coverage Research History >

NOL STOCK CHART

FNArena News on NOL

1	FNArena Corporate Results Monitor – 01-09-2025 Sep 01 2025 - Australia

2	FNArena Corporate Results Monitor – 03-03-2025 Mar 03 2025 - Australia

3	FNArena Corporate Results Monitor – 02-09-2024 Sep 02 2024 - Australia

4	Next Week At A Glance – 22-26 July 2024 Jul 19 2024 - Weekly Reports

5	FNArena Corporate Results Monitor – 29-02-2024 Feb 29 2024 - Australia

Latest Insurance News

1	Insurers To Pamper Shareholders With Buybacks Jan 24 2025 - Australia

2	IAG Shares Breaking Out Jan 21 2025 - Technicals

3	ESG Focus: The Little Big Things – 21-11-2024 Nov 21 2024 - ESG Focus

4	New-Look Suncorp Ready To Rumble Nov 14 2024 - Australia

5	Steadfast’s Long March Jul 02 2024 - Australia

6	AUB Group Shares Poised For Break-Out Jun 13 2024 - Technicals

7	SMSFundamentals: Older People Are Life Insurers’ Future Challenge Oct 26 2023 - SMSFundamentals

8	Australian Insurers And The Weather Oct 19 2023 - Feature Stories

9	Steadfast Group’s US Entry Full Of Promise Oct 11 2023 - Australia

10	Pros And Cons Of Insurance Companies Aug 02 2023 - Australia

Dividend Yield Today On Last Actual Payout :	0.00
Estimated Dividend Growth (Average Of Past Three Years)	%
Amount Invested	$
Tell Me The Dividend After This Many Years

	Yield	Yield on investment
This Year
Year 1
Year 2
Year 3
Year 4
Year

Get 2 Weeks free trial

Sign Up

Member Login

NOBLEOAK LIFE LIMITED (NOL)
Share Price Analysis and Chart